{"id":"https://openalex.org/W2052689271","doi":"https://doi.org/10.1517/13543780902780175","title":"Review of rifaximin as treatment for SIBO and IBS","display_name":"Review of rifaximin as treatment for SIBO and IBS","alternate_titles":[],"publication_year":2009,"publication_date":"2009-03-01","ids":{"openalex":"https://openalex.org/W2052689271","doi":"https://doi.org/10.1517/13543780902780175","mag":"2052689271","pmid":"https://pubmed.ncbi.nlm.nih.gov/19243285"},"language":"en","primary_location":{"id":"doi:10.1517/13543780902780175","doi":"https://doi.org/10.1517/13543780902780175","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543780902780175","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2052689271"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034864639","display_name":"Mark Pimentel","orcid":"https://orcid.org/0000-0002-0619-5115","observed_orcids":["https://orcid.org/0000-0002-0619-5115"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Mark Pimentel","raw_affiliation_strings":["GI Motility Program, Cedars-Sinai Medical Center, 8730 Alden Dr, Suite 225E, Los Angeles, CA 90048, USA. Mark.Pimentel@cshs.org","Director GI Motility Program, Cedars-Sinai Medical Center, 8730 Alden Dr, Suite 225E, Los Angeles, CA 90048, USA +1 310 423 6143"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GI Motility Program, Cedars-Sinai Medical Center, 8730 Alden Dr, Suite 225E, Los Angeles, CA 90048, USA. Mark.Pimentel@cshs.org","institution_ids":["https://openalex.org/I1282927834"]},{"raw_affiliation_string":"Director GI Motility Program, Cedars-Sinai Medical Center, 8730 Alden Dr, Suite 225E, Los Angeles, CA 90048, USA +1 310 423 6143","institution_ids":["https://openalex.org/I1282927834"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5034864639"],"corresponding_institution_ids":["https://openalex.org/I1282927834"],"apc_list":null,"apc_paid":null,"fwci":1.535,"has_fulltext":false,"cited_by_count":137,"citation_normalized_percentile":{"value":0.81280788,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"18","issue":"3","first_page":"349","last_page":"358"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10365","display_name":"Gastrointestinal motility and disorders","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10365","display_name":"Gastrointestinal motility and disorders","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10066","display_name":"Gut microbiota and health","score":0.010300000198185444,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13569","display_name":"Microscopic Colitis","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rifaximin","display_name":"rifaximin","score":1.0},{"id":"https://openalex.org/keywords/small-intestinal-bacterial-overgrowth","display_name":"small intestinal bacterial overgrowth","score":0.9750000238418579},{"id":"https://openalex.org/keywords/irritable-bowel-syndrome","display_name":"irritable bowel syndrome","score":1.0},{"id":"https://openalex.org/keywords/antibiotic-resistance","display_name":"antibiotic resistance","score":0.6549999713897705},{"id":"https://openalex.org/keywords/metronidazole","display_name":"metronidazole","score":0.8159999847412109},{"id":"https://openalex.org/keywords/levofloxacin","display_name":"levofloxacin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8550000190734863},{"id":"https://openalex.org/keywords/gut-microbiota","display_name":"gut microbiota","score":0.6330000162124634}],"concepts":[{"id":"https://openalex.org/C2778889925","wikidata":"https://www.wikidata.org/wiki/Q416073","display_name":"Rifaximin","level":3,"score":0.9794530868530273},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5779618620872498},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5511816740036011},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5489799976348877},{"id":"https://openalex.org/C2778271842","wikidata":"https://www.wikidata.org/wiki/Q838966","display_name":"Irritable bowel syndrome","level":2,"score":0.5072240829467773},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.19747453927993774},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16819962859153748},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.10457828640937805}],"mesh":[{"descriptor_ui":"D000078262","descriptor_name":"Rifaximin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007410","descriptor_name":"Intestinal Diseases","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D007410","descriptor_name":"Intestinal Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007410","descriptor_name":"Intestinal Diseases","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":true},{"descriptor_ui":"D012294","descriptor_name":"Rifamycins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012294","descriptor_name":"Rifamycins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012294","descriptor_name":"Rifamycins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012294","descriptor_name":"Rifamycins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D050296","descriptor_name":"Microbial Viability","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1517/13543780902780175","doi":"https://doi.org/10.1517/13543780902780175","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543780902780175","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:19243285","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19243285","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W119395284","https://openalex.org/W137398571","https://openalex.org/W1587016945","https://openalex.org/W1851970679","https://openalex.org/W1972667757","https://openalex.org/W1972769042","https://openalex.org/W1994240009","https://openalex.org/W1995504800","https://openalex.org/W1996001370","https://openalex.org/W1999969457","https://openalex.org/W2002639095","https://openalex.org/W2003111718","https://openalex.org/W2007435811","https://openalex.org/W2016005958","https://openalex.org/W2026332875","https://openalex.org/W2049851010","https://openalex.org/W2051060917","https://openalex.org/W2052498454","https://openalex.org/W2061619758","https://openalex.org/W2077005896","https://openalex.org/W2083325871","https://openalex.org/W2086554485","https://openalex.org/W2088160772","https://openalex.org/W2097707664","https://openalex.org/W2103771013","https://openalex.org/W2108401684","https://openalex.org/W2117322018","https://openalex.org/W2119605026","https://openalex.org/W2133926562","https://openalex.org/W2141397074","https://openalex.org/W2146147731","https://openalex.org/W2166623682","https://openalex.org/W2168259047","https://openalex.org/W2185727926","https://openalex.org/W2406835419","https://openalex.org/W2430285748","https://openalex.org/W2977308836"],"related_works":["https://openalex.org/W1002756680","https://openalex.org/W2169328643","https://openalex.org/W2113472299","https://openalex.org/W1652108323","https://openalex.org/W2977822116","https://openalex.org/W4409471642","https://openalex.org/W2329025690","https://openalex.org/W3001750915","https://openalex.org/W2578484558","https://openalex.org/W962900825"],"abstract_inverted_index":{"BACKGROUND:":[0],"Rifaximin":[1,58,87],"is":[2],"a":[3,89,103],"broad-range,":[4],"gastrointestinal-specific":[5],"antibiotic":[6,115],"that":[7],"demonstrates":[8],"no":[9],"clinically":[10,113],"relevant":[11,114],"bacterial":[12,28,38],"resistance.":[13,116],"Therefore,":[14],"rifaximin":[15,44,54],"may":[16,101],"be":[17],"useful":[18],"in":[19,62,71],"the":[20],"treatment":[21,46],"of":[22,47,53,66,75,92],"gastrointestinal":[23],"disorders":[24],"associated":[25],"with":[26,77,79,96],"altered":[27],"flora,":[29],"including":[30],"irritable":[31],"bowel":[32],"syndrome":[33],"(IBS)":[34],"and":[35,49,68,100],"small":[36],"intestinal":[37],"overgrowth":[39],"(SIBO).":[40],"OBJECTIVE:":[41],"To":[42],"review":[43],"for":[45],"IBS":[48],"SIBO.":[50],"METHODS:":[51],"Review":[52],"clinical":[55],"trials.":[56],"RESULTS/CONCLUSION:":[57],"improved":[59],"global":[60],"symptoms":[61],"33":[63],"-":[64],"92%":[65],"patients":[67,76],"eradicated":[69],"SIBO":[70],"up":[72,82],"to":[73,83],"84%":[74],"IBS,":[78],"results":[80],"sustained":[81],"10":[84],"weeks":[85],"post-treatment.":[86],"caused":[88],"lower":[90],"number":[91],"adverse":[93,106],"events":[94],"compared":[95],"metronidazole":[97],"or":[98],"levofloxacin":[99],"have":[102],"more":[104],"favorable":[105],"event":[107],"profile":[108],"than":[109],"systemic":[110],"antibiotics,":[111],"without":[112]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2052689271","counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
